The observed relationship between RBP4 and TNM staging in CRC is consistent with studies indicating that higher RBP4 serum levels are linked to advanced disease and poor survival, also in breast cancer, where RBP4 was shown to correlate with ER- and PR-negative status, which results in a more unfavorable prognosis [41]. Here, RBP4 is linked to breast cancer.